FRANKLIN RESOURCES INC - CYTOMX THERAPEUTICS INC ownership

CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 68 filers reported holding CYTOMX THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.30 and the average weighting 0.0%.

Quarter-by-quarter ownership
FRANKLIN RESOURCES INC ownership history of CYTOMX THERAPEUTICS INC
ValueSharesWeighting
Q4 2023$41,599
+20.2%
26,8380.0%0.00%
Q3 2023$34,621
-40.9%
26,838
-21.3%
0.00%
Q2 2023$58,624
+13.9%
34,0840.0%0.00%
Q1 2023$51,467
-5.6%
34,0840.0%0.00%
Q4 2022$54,534
+11.3%
34,0840.0%0.00%
Q3 2022$49,000
-21.0%
34,0840.0%0.00%
Q2 2022$62,000
-54.1%
34,084
-32.7%
0.00%
Q1 2022$135,000
-38.4%
50,6790.0%0.00%
Q4 2021$219,000
-15.4%
50,679
-0.2%
0.00%
Q3 2021$259,000
-95.8%
50,800
-84.8%
0.00%
-100.0%
Q3 2018$6,171,000
-19.1%
333,5760.0%0.00%
-25.0%
Q2 2018$7,626,000
-19.6%
333,576
+0.0%
0.00%
-20.0%
Q1 2018$9,488,000
+34.8%
333,5000.0%0.01%
+66.7%
Q4 2017$7,040,000
+16.2%
333,5000.0%0.00%0.0%
Q3 2017$6,060,000
+17.2%
333,5000.0%0.00%0.0%
Q2 2017$5,169,000
-10.3%
333,5000.0%0.00%0.0%
Q1 2017$5,760,000
+57.2%
333,5000.0%0.00%
+50.0%
Q4 2016$3,665,000
-29.9%
333,5000.0%0.00%
-33.3%
Q3 2016$5,229,000
+53.5%
333,5000.0%0.00%
+50.0%
Q2 2016$3,407,000
-12.0%
333,500
+11.2%
0.00%0.0%
Q1 2016$3,870,000
-38.2%
300,0000.0%0.00%
-33.3%
Q4 2015$6,261,000300,0000.00%
Other shareholders
CYTOMX THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Canaan Partners IX LLC 4,244,381$43,378,000100.00%
VHCP Management II, LLC 577,831$5,905,0003.56%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 71,366$729,0002.45%
Casdin Capital, LLC 234,179$2,392,0002.38%
BVF INC/IL 606,138$6,192,0001.32%
Opaleye Management Inc. 160,000$1,634,0001.09%
Redmile Group, LLC 733,899$7,497,0000.72%
VHCP Management, LLC 64,200$656,0000.68%
Montecito Bank & Trust 146,544$1,497,0000.63%
Cormorant Asset Management, LP 371,636$3,796,0000.54%
View complete list of CYTOMX THERAPEUTICS INC shareholders